Clinical Trials in Bryant, Arkansas

Find clinical trials in Bryant, Arkansas. Discover local research opportunities and treatment options in your area.

9 Active Trials Found in Bryant

Showing 9 trials on this page

Page 1 of 1

A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)

NCT ID: NCT05882877

This clinical trial is studying a medication called rocatinlimab to see how safe it is and how well it works for people aged 12 and older who have moderate to severe atopic dermatitis, which is a t...

Recruiting

Phase: PHASE3 Conditions: Atopic Dermatitis

A Study of LY4100511 (DC-853) in Adult Participants With Moderate-to-Severe Plaque Psoriasis

NCT ID: NCT06602219

This clinical trial is studying a new treatment called LY4100511 (also known as DC-853) for adult patients who have moderate-to-severe plaque psoriasis, a common skin condition that causes red, sca...

Recruiting

Phase: PHASE2 Conditions: Plaque Psoriasis

A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

NCT ID: NCT06468228

This clinical trial is studying a new drug called lutikizumab to see how well it works and how safe it is for treating moderate to severe hidradenitis suppurativa (HS), a painful skin condition tha...

Recruiting

Phase: PHASE3 Conditions: Hidradenitis Suppurativa

Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

NCT ID: NCT06559306

This clinical trial is studying a medication called seltorexant to see how well it helps adults and elderly people who have major depressive disorder (MDD) along with insomnia symptoms. The goal is...

Recruiting

Phase: PHASE3 Conditions: Depressive Disorder, Major

A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder

NCT ID: NCT06254612

This clinical trial is studying a new treatment called SP-624 for adults who have Major Depressive Disorder (MDD), a serious condition that affects mood and daily life. The trial is in its second p...

Recruiting

Phase: PHASE2 Conditions: Major Depressive Disorder

ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

NCT ID: NCT07011706

This clinical trial is studying a new medication called ATI-045 to see how well it works compared to a placebo (a non-active treatment) for people with moderate-to-severe atopic dermatitis, which i...

Recruiting

Phase: PHASE2 Conditions: Atopic Dermatitis, Eczema +3 more

Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

NCT ID: NCT05769777

This clinical trial is looking at a new treatment called amlitelimab for people aged 12 and older who have moderate to severe atopic dermatitis, also known as eczema. The goal is to see how safe an...

Recruiting

Phase: PHASE2 Conditions: Dermatitis Atopic

Safety Study of Roflumilast Cream 0.05% in Infants Aged 3 Months to Less Than 2 Years With Atopic Dermatitis

NCT ID: NCT06998056

This clinical trial is studying a cream called Roflumilast (0.05%) to see how safe it is for infants aged 3 months to less than 2 years who have atopic dermatitis, which is also known as eczema. Th...

Recruiting

Phase: PHASE2 Conditions: Atopic Dermatitis (Eczema)

Study Comparing Tapinarof Cream 1% to VTAMA ® (Tapinarof Cream 1%) in the Treatment of Plaque Psoriasis

NCT ID: NCT06742957

This clinical trial is studying a cream called Tapinarof, which is being compared to a similar product known as VTAMA® for treating plaque psoriasis, a skin condition that causes red, scaly patches...

Recruiting

Phase: PHASE3 Conditions: Plaque Type Psorisis

Search All Trials Browse All Locations